Skip to content
Assyro AI
FDA Orange Book · active-ingredient family

Choline c-11

Choline c-11: 1 brand, 4 generics; first approved Sep 12, 2012; generic available.

Generic availableHas discontinued products
Generic status & protection

Generic available: 4 ANDA applications approved.

Brands (NDA)
1
Generics (ANDA)
4
Listed patents
0
Presentations
5

Brand (NDA) products

Originator applications
Ask AI
  • CHOLINE C-11RLDRS
    NDA 2031552012
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    4-33.1mCi/MLINJECTABLEINTRAVENOUSRxAP

Generic (ANDA) products (4)

Abbreviated applications
Ask AI
  • CHOLINE C-11
    ANDA 2084442017
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    4-33.1mCi/MLINJECTABLEINTRAVENOUSDiscontinued-
  • CHOLINE C-11
    ANDA 2084132017
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    4-33.1mCi/MLINJECTABLEINTRAVENOUSDiscontinued-
  • CHOLINE C-11
    ANDA 2063192015
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    4-33.1mCi/MLINJECTABLEINTRAVENOUSRxAP
  • CHOLINE C-11
    ANDA 2056902015
    Approved strengths under this FDA application.
    StrengthDosage formRouteStatusTE
    4-100mCi/MLINJECTABLEINTRAVENOUSDiscontinued-

Listed patents

Orange Book patent file

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Approval history

FDA approval span
Ask AI
First approval
14 yr 4 mo ago
Most recent approval
9 yr 1 mo ago

Approvals span 2012–2017 across 5 FDA applications.

Brand (NDA) 120%
Generic (ANDA) 480%

Choline c-11: frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Built directly from the FDA Orange Book data file (products, patents, and exclusivity). TE codes, RLD/RS flags, patent expirations, and exclusivity dates match the official FDA record. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Related FDA reference tools

Assyro Intelligence

Ask anything about Choline c-11

Cited answers from FDA, EMA, Health Canada, PubMed and ClinicalTrials.gov, in seconds. Free, no sign-up.

  • PubMed
  • ClinicalTrials.gov
  • FDA
  • Health Canada
  • EMA
  • ICH

Evaluating for a team? Book a demo